Structural dynamics of the human androgen receptor: implications for prostate cancer and neurodegenerative disease

J. Duff, P. Davies, K. Watt, Iain Joseph McEwan

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

The AR (androgen receptor) is a ligand-activated transcription factor that mediates the action of the steroids testosterone and dihydrotestosterone. Alterations in the AR gene result in a number of clinical disorders, including: androgen-insensitivity, which leads to disruption of male development; prostate cancer; and a neuromuscular degenerative condition termed spinal bulbar muscular atrophy or Kennedy's disease. The AR gene is X-linked and the protein is coded for by eight exons, giving rise to a C-terminal LBD (ligand-binding domain; exons 4-8), linked by a hinge region (exon 4) to a Zn-finger DBD (DNA-binding domain; exons 2 and 3) and a large structurally distinct NTD (N-terminal domain; exon 1). identification and characterization of mutations found in prostate cancer and Kennedy's disease patients have revealed the importance of structural dynamics in the mechanisms of action of receptors. Recent results from our laboratory studying genetic changes in the LBD and the structurally flexible NTD will be discussed.

Original languageEnglish
Pages (from-to)1098-1102
Number of pages5
JournalBiochemical Society Transactions
Volume34
DOIs
Publication statusPublished - 2006

Keywords

  • dihydrotestosterone
  • human androgen receptor
  • ligand-binding domain
  • prostate cancer
  • spinal bulbar muscular atrophy
  • transactivation domain
  • coactivator interactions
  • polyglutamine
  • protein
  • domain
  • transactivation
  • conformation
  • activation
  • expansion
  • peptides
  • ATAXIN-3

Cite this

Structural dynamics of the human androgen receptor : implications for prostate cancer and neurodegenerative disease. / Duff, J.; Davies, P.; Watt, K.; McEwan, Iain Joseph.

In: Biochemical Society Transactions, Vol. 34, 2006, p. 1098-1102.

Research output: Contribution to journalArticle

@article{457fd99174ba4a42ab2319e7191075b7,
title = "Structural dynamics of the human androgen receptor: implications for prostate cancer and neurodegenerative disease",
abstract = "The AR (androgen receptor) is a ligand-activated transcription factor that mediates the action of the steroids testosterone and dihydrotestosterone. Alterations in the AR gene result in a number of clinical disorders, including: androgen-insensitivity, which leads to disruption of male development; prostate cancer; and a neuromuscular degenerative condition termed spinal bulbar muscular atrophy or Kennedy's disease. The AR gene is X-linked and the protein is coded for by eight exons, giving rise to a C-terminal LBD (ligand-binding domain; exons 4-8), linked by a hinge region (exon 4) to a Zn-finger DBD (DNA-binding domain; exons 2 and 3) and a large structurally distinct NTD (N-terminal domain; exon 1). identification and characterization of mutations found in prostate cancer and Kennedy's disease patients have revealed the importance of structural dynamics in the mechanisms of action of receptors. Recent results from our laboratory studying genetic changes in the LBD and the structurally flexible NTD will be discussed.",
keywords = "dihydrotestosterone, human androgen receptor, ligand-binding domain, prostate cancer, spinal bulbar muscular atrophy, transactivation domain, coactivator interactions, polyglutamine, protein, domain, transactivation, conformation, activation, expansion, peptides, ATAXIN-3",
author = "J. Duff and P. Davies and K. Watt and McEwan, {Iain Joseph}",
year = "2006",
doi = "10.1042/BST0341098",
language = "English",
volume = "34",
pages = "1098--1102",
journal = "Biochemical Society Transactions",
issn = "0300-5127",
publisher = "Portland Press Ltd.",

}

TY - JOUR

T1 - Structural dynamics of the human androgen receptor

T2 - implications for prostate cancer and neurodegenerative disease

AU - Duff, J.

AU - Davies, P.

AU - Watt, K.

AU - McEwan, Iain Joseph

PY - 2006

Y1 - 2006

N2 - The AR (androgen receptor) is a ligand-activated transcription factor that mediates the action of the steroids testosterone and dihydrotestosterone. Alterations in the AR gene result in a number of clinical disorders, including: androgen-insensitivity, which leads to disruption of male development; prostate cancer; and a neuromuscular degenerative condition termed spinal bulbar muscular atrophy or Kennedy's disease. The AR gene is X-linked and the protein is coded for by eight exons, giving rise to a C-terminal LBD (ligand-binding domain; exons 4-8), linked by a hinge region (exon 4) to a Zn-finger DBD (DNA-binding domain; exons 2 and 3) and a large structurally distinct NTD (N-terminal domain; exon 1). identification and characterization of mutations found in prostate cancer and Kennedy's disease patients have revealed the importance of structural dynamics in the mechanisms of action of receptors. Recent results from our laboratory studying genetic changes in the LBD and the structurally flexible NTD will be discussed.

AB - The AR (androgen receptor) is a ligand-activated transcription factor that mediates the action of the steroids testosterone and dihydrotestosterone. Alterations in the AR gene result in a number of clinical disorders, including: androgen-insensitivity, which leads to disruption of male development; prostate cancer; and a neuromuscular degenerative condition termed spinal bulbar muscular atrophy or Kennedy's disease. The AR gene is X-linked and the protein is coded for by eight exons, giving rise to a C-terminal LBD (ligand-binding domain; exons 4-8), linked by a hinge region (exon 4) to a Zn-finger DBD (DNA-binding domain; exons 2 and 3) and a large structurally distinct NTD (N-terminal domain; exon 1). identification and characterization of mutations found in prostate cancer and Kennedy's disease patients have revealed the importance of structural dynamics in the mechanisms of action of receptors. Recent results from our laboratory studying genetic changes in the LBD and the structurally flexible NTD will be discussed.

KW - dihydrotestosterone

KW - human androgen receptor

KW - ligand-binding domain

KW - prostate cancer

KW - spinal bulbar muscular atrophy

KW - transactivation domain

KW - coactivator interactions

KW - polyglutamine

KW - protein

KW - domain

KW - transactivation

KW - conformation

KW - activation

KW - expansion

KW - peptides

KW - ATAXIN-3

U2 - 10.1042/BST0341098

DO - 10.1042/BST0341098

M3 - Article

VL - 34

SP - 1098

EP - 1102

JO - Biochemical Society Transactions

JF - Biochemical Society Transactions

SN - 0300-5127

ER -